Disease-A-Month
Volume 54, Issue 7 , Pages 419-431 , July 2008

Overview of Liver Pathology

References 

  1. Saxena R, Theise ND, Crawford JM. Microanatomy of the human liver-exploring the hidden interfaces. Hepatology. 1999;30(6):1339–1346
  2. Jungermann K, Kietzmann T. Zonation of parenchymal and nonparenchymal metabolism in liver. Annu Rev Nutr. 1996;16:179–203
  3. Crawford JM. The liver and biliary tree. In:  Kumar V,  Abbas AK,  Fausto N editor. Robbins Pathologic Basis of Disease. 7th ed.. Philadelphia, PA: WB Saunders; 2004;p. 878–879
  4. Roskams T. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene. 2006;25:3818–3822
  5. Crawford JM. Development of the intrahepatic biliary tree. Semin Liver Dis. 2002;22:213–226
  6. Scotto J, Opolon P, Eteve J, et al. Liver biopsy and prognosis in acute liver failure. Gut. 1973;14:927–933
  7. Donaldson BW, Gopinath R, Wanless IR, et al. The role of transjugular liver biopsy in fulminant liver failure: relation to other prognostic indicators. Hepatology. 1993;18:1370–1376
  8. Gill RQ, Sterling RK. Acute liver failure. J Clin Gastroenterol. 2001;33:191–198
  9. Sell S. Heterogeneity and plasticity of hepatocyte lineage cells. Hepatology. 2001;33:738–750
  10. Batts KP, Ludwig J. Chronic hepatitis (An update on terminology and reporting). Am J Surg Pathol. 1995;19:1409–1417
  11. Friedman SL. Evaluation of fibrosis and hepatitis C. Am J Med. 1999;107(6B):27S–30S
  12. Shaheen AA, Wan AF, Myers RP. FibroTest and FibroScan for the prediction of hepatitis c-related fibrosis: a systematic review of diagnostic test accuracy. Am J Gastroenterol. 2007;102:2589–2600
  13. Kim KM, Choi WB, Park SH, et al. Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potential liver donors. J Gastroenterol. 2007;42:382–388
  14. Sciot R, Paterson AC, van Eyken P, et al. Transferrin receptor expression in human hepatocellular carcinoma: an immunohistochemical study of 34 cases. Histopathology. 1988;12:53–63
  15. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet. 2002;31:339–346
  16. El-Serag HB. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology. 2002;36:S74–S83
  17. Edwards BK, Brown ML, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst. 2005;97:1407–1427
  18. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–1917
  19. Llovet JM, Fuster J, Bruix J. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl. 2004;10:S115–S120
  20. Demetris A, Adams D, Bellamy C, et al. Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection (An International Panel). Hepatology. 2000;31:792–799

PII: S0011-5029(08)00042-4

doi: 10.1016/j.disamonth.2008.03.007

Disease-A-Month
Volume 54, Issue 7 , Pages 419-431 , July 2008

Article Tools

* Image Usage & Resolution